Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.

Autor: Ben-Ami R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Zhang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Supplee JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lehmann-Werman R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Nowak J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Loftus M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davidi T; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Zick A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Hubert A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Neiman D; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Piyanzin S; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Gal-Rosenberg O; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Horn A; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Shemer R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Glaser B; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel., Boos N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Jajoo K; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lee L; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Clancy TE; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chabot JA; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., Kastrinos F; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA., Kluger M; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bardeesy N; Massachusetts General Hospital Cancer Center, Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA., Stanger B; Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., O'Hara MH; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Till J; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Maitra A; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA., Carpenter EL; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bullock AJ; Division of Hematology and Oncology, Beth-Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Genkinger J; Department of epidemiology, Mailman school of public health, Columbia university, New York, New York, USA.; Herbert Irving Comprehensive Cancer Center, Columbia university Irving Medical Center, New York, New York, USA., Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Dor Y; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Gut [Gut] 2024 Mar 07; Vol. 73 (4), pp. 639-648. Date of Electronic Publication: 2024 Mar 07.

Sodium-Dependent Regenerative Responses in Dendrites of Axotomized Motoneurons in the Cat

Autor: Sernagor, Evelyne, Yarom, Y., Werman, R.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1986 Oct . 83(20), 7966-7970.

Externí odkaz: https://www.jstor.org/stable/28218

A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer.

Autor: Grinshpun A; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Kustanovich A; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel., Neiman D; Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel., Lehmann-Werman R; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel.; Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel., Zick A; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Meir K; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel.; Department of Pathology, Hadassah Medical Center, Jerusalem, Israel., Vainer E; Department of Gastroenterology, Hadassah Medical Center, Jerusalem, Israel., Granit RZ; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel., Arad A; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Daskal N; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Schwartz R; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel., Sapir E; Radiotherapy Unit, Assuta Medical Center, Ashdod, Israel., Maoz M; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel., Tahover E; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel.; Gastrointestinal Oncology Service, Department of Oncology, Sha'are Zedek Medical Center, Jerusalem, Israel., Moss J; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel.; Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel., Ben-Dov IZ; Department of Nephrology and Hypertension, Hadassah Medical Center, Jerusalem, Israel., Peretz T; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Hubert A; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Hebrew University, Jerusalem, Israel., Shemer R; Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel., Dor Y; Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Apr 01; Vol. 152 (7), pp. 1444-1451. Date of Electronic Publication: 2022 Dec 14.

Tetraethylammonium Ions: Effect of Presynaptic Injection on Synaptic Transmission

Autor: Kusano, K., Livengood, D. R., Werman, R.

Publikováno v: Science, 1967 Mar 01. 155(3767), 1257-1259.

Externí odkaz: https://www.jstor.org/stable/1720148

Detection of Brain-Derived Cell-Free DNA in Plasma.

Autor: Pellegrini, Camilla¹ (AUTHOR) camilla.pellegrini@ausl.bologna.it, Ravaioli, Francesco¹ (AUTHOR) francesco.ravaioli@ausl.bologna.it, De Fanti, Sara¹ (AUTHOR) sara.defanti@ausl.bologna.it, Pirazzini, Chiara² (AUTHOR) chiara.pirazzini5@unibo.it, D'Silva, Chiara³ (AUTHOR) chiara.dsilva2@unibo.it, Garagnani, Paolo^2,4 (AUTHOR) francesca.bonifazi@unibo.it, Franceschi, Claudio⁵ (AUTHOR) claudio.franceschi@unibo.it, Bonifazi, Francesca⁴ (AUTHOR), Zinzani, Pier Luigi^2,6 (AUTHOR) pierluigi.zinzani@unibo.it, Bonafè, Massimiliano^2,4 (AUTHOR) massimiliano.bonafe@unibo.it, Guarino, Maria¹ (AUTHOR) maria.guarino@isnb.it, Lodi, Raffaele^1,7 (AUTHOR) raffaele.lodi@isnb.it, Cortelli, Pietro^1,7 (AUTHOR) pietro.cortelli@isnb.it, Tonon, Caterina^1,7 (AUTHOR) caterina.tonon@isnb.it, Mitolo, Micaela⁸ (AUTHOR) micaela.mitolo@unipr.it, Sambati, Luisa¹ (AUTHOR) luisa.sambati@isnb.it, Morandi, Luca^1,7 (AUTHOR) luca.morandi2@unibo.it, Bacalini, Maria Giulia¹ (AUTHOR) mariagiulia.bacalini@ausl.bologna.it

Publikováno v: Diagnostics (2075-4418). Nov2024, Vol. 14 Issue 22, p2541. 15p.